Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaginal bromocriptine for pain and menstrual bleeding in adenomyosis
IRCT20240806062668N3Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Apr 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of bromocriptine in adenomyosis, sponsored by Tabriz University of Medical Sciences. Started Apr 2025; status: completed.
02
Drugs
bromocriptine
03
Conditions
adenomyosis
Beyond the preview
Go deeper on IRCT20240806062668N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240806062668N3.